Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy.
Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Stanisavljevic D, Dugalic MG, Sengul D, Detanac DA, Sengul I, Detanac D, Soares JM Junior.
Gutic B, et al. Among authors: detanac da.
Clinics (Sao Paulo). 2023 Mar 14;78:100177. doi: 10.1016/j.clinsp.2023.100177. eCollection 2023.
Clinics (Sao Paulo). 2023.
PMID: 36931099
Free PMC article.
Review.